CLINICAL_TRIALS
trial_result
· 2017-03-22
Clinical Trial Update: Effects of Aliskiren on Patient With Heart Failure and a Normal Ejection Fraction [Phase 4]
Summary
Phase 4 trial update evaluating aliskiren in patients with heart failure and preserved ejection fraction.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2017-03-22